Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Seralutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93,099Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gossamer Bio To Participate In Upcoming Investor Conferences
    Gossamer Bio To Participate In Upcoming Investor Conferences

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124688603/en/Gossamer-Bio-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Gossamer Bio To Participate In Upcoming Investor Conferences
    Gossamer Bio To Participate In Upcoming Investor Conferences

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107017321/en/Gossamer-Bio-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)
    Gossamer Bio Announces Inducement Grant Under Nasdaq LR 5635(c)(4)

    07 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250207717407/en

    BUSINESSWIRE
    07 Feb 2025
    Share Share
    Gossamer Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
    Gossamer Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241007084198/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Gossamer To Provide Seralutinib OLE Data At ATS 2024
    Gossamer To Provide Seralutinib OLE Data At ATS 2024

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514616477/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Chiesi and Gossamer Bio collaborate to develop Seralutinib for PAH
    Chiesi and Gossamer Bio collaborate to develop Seralutinib for PAH

    06 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chiesi-and-gossamer-bio-announce-transformative-global-collaboration-to-develop-and-commercialize-seralutinib-in-pulmonary-arterial-hypertension-and-other-respiratory-indications-302136742.html

    PR NEWSWIRE
    06 May 2024
    Share Share